Skip to main content

CD57+CD4 T Cells and Belatacept Resistant Rejection.

Conferences
Espinosa, J; Bosinger, S; Farris, A; Song, M; Stempora, L; Tharp, G; Townsend, R; Kirk, A
Published in: Transplantation
July 2014

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Transplantation

DOI

ISSN

0041-1337

Publication Date

July 2014

Volume

98

Start / End Page

141 / 141

Publisher

Ovid Technologies (Wolters Kluwer Health)

Related Subject Headings

  • Surgery
  • 3204 Immunology
  • 3202 Clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Espinosa, J., Bosinger, S., Farris, A., Song, M., Stempora, L., Tharp, G., … Kirk, A. (2014). CD57+CD4 T Cells and Belatacept Resistant Rejection. In Transplantation (Vol. 98, pp. 141–141). Ovid Technologies (Wolters Kluwer Health). https://doi.org/10.1097/00007890-201407151-00434
Espinosa, J., S. Bosinger, A. Farris, M. Song, L. Stempora, G. Tharp, R. Townsend, and A. Kirk. “CD57+CD4 T Cells and Belatacept Resistant Rejection.” In Transplantation, 98:141–141. Ovid Technologies (Wolters Kluwer Health), 2014. https://doi.org/10.1097/00007890-201407151-00434.
Espinosa J, Bosinger S, Farris A, Song M, Stempora L, Tharp G, et al. CD57+CD4 T Cells and Belatacept Resistant Rejection. In: Transplantation. Ovid Technologies (Wolters Kluwer Health); 2014. p. 141–141.
Espinosa, J., et al. “CD57+CD4 T Cells and Belatacept Resistant Rejection.Transplantation, vol. 98, Ovid Technologies (Wolters Kluwer Health), 2014, pp. 141–141. Crossref, doi:10.1097/00007890-201407151-00434.
Espinosa J, Bosinger S, Farris A, Song M, Stempora L, Tharp G, Townsend R, Kirk A. CD57+CD4 T Cells and Belatacept Resistant Rejection. Transplantation. Ovid Technologies (Wolters Kluwer Health); 2014. p. 141–141.

Published In

Transplantation

DOI

ISSN

0041-1337

Publication Date

July 2014

Volume

98

Start / End Page

141 / 141

Publisher

Ovid Technologies (Wolters Kluwer Health)

Related Subject Headings

  • Surgery
  • 3204 Immunology
  • 3202 Clinical sciences